Search This Blog

Monday, October 17, 2022

China Indefinitely Delays Reporting Key Economic Data Amid National Congress

 The world's second largest economy announced overnight - with no explanation - that is will be indefinitely delaying the release of a slew of economic data including the much-anticipated GDP growth data that has occurred during a period when the much-vaunted Zero-COVID policy has dominated Chinese life.

“I've not come across before a situation where a whole raft of statistical reporting has just been postponed, in nearly half a century of monitoring data releases — not even in times of pestilence and conflict,” said George Magnus, a former chief economist of UBS who is now an associate at the China Center at Oxford University.

The timing is interesting since it comes as as the country's ruling elite has gathered in Beijing for the twice-a-decade national congress of the Communist Party, and the expected miss (+3.4% expected vs +5.5% plan) of the party's planned growth targets would have been embarrassing for the party, coming just two days after newly re-crowned Chinese leader Xi Jinping gave a rousing and confident address at the opening of the week-long 20th Communist Party Congress.

The unexplained delay is all the more surprising because Zhao Chenxin, the deputy director of the National Development and Reform Commission, had taken an upbeat tone about the Chinese economy during a news conference on Monday morning at the media center of the party congress.

“Judging from the current situation, the economy rebounded significantly in the third quarter — from a global perspective, China’s economic performance is still outstanding,” he said.

Another agency, the General Administration of Customs, had separately failed last Friday to follow its own previously issued schedule for the release of export and import statistics for September. The release of those numbers has also been delayed indefinitely.

Mr. Zhao said on Monday morning that because of the government’s pandemic policies and emphasis on economic development, “China’s economic stabilization and improvement will be further consolidated.”

AsiaFinancial reports that a person answering the telephone in the media office at the National Bureau of Statistics (NBS) said the change was “due to adjustment to work arrangements” but gave no further details.

As a reminder, China's economy grew at just 0.4% in Q2...

The Economist Intelligence Unit's Nick Marro summed things up very succinctly...

To illustrate just how dire things look, QZ reports that Robin Brooks, chief economist at the Institute of International Finance, recently made a quick calculation: if China manages zero GDP growth in its third and fourth quarters, it would be in some economically unenviable company; only Russia, Sri Lanka, and Ukraine would have seen weaker annual growth for 2022.

https://www.zerohedge.com/economics/china-indefinitely-delays-reporting-key-economic-data-amid-national-congress

RSV, a virus that can severely sicken infants, is filling hospital beds

 On Sunday night, 4-month-old Aesop Light was happy and alert. By Monday morning, he was struggling to breathe.

Aesop’s parents, Corey and Tara Light, took him to an emergency room near their home in the Chicago suburbs, but it didn’t have a children’s wing, so Aesop was rushed by ambulance to another hospital an hour away. He tested positive for respiratory syncytial virus, or RSV, a common virus that causes lung infections.

Aesop’s condition “went downhill really fast,” Tara said.

Hospitals across the country have reported a surge in RSV cases over the last three to four weeks. The virus began circulating in the summer, to doctors’ surprise, since it usually peaks in winter.

For many kids, RSV symptoms look like a common cold. But for others — young babies or children with lung diseases or weakened immune systems — symptoms can be more severe.

“The ones who tend to get the most sick are the infants below four months. And then the ones who are older who tend to get most sick are those who have some other medical conditions,” said Dr. Sameer Kamath, chief medical officer for Duke Children’s Hospital and Health Center.

RSV can lead to bronchiolitis, an infection that causes airways to become inflamed and clogged with mucus, making it difficult to breathe. If the infection travels to the lung sacs, it can result in pneumonia.

According to the Centers for Disease Control and Prevention, RSV results in around 58,000 annual hospitalizations and 100 to 300 deaths among children under 5.

Aesop was moved to a pediatric ICU on Tuesday after his heart and breathing rates soared. Tara has been staying with him in the hospital, since she still breastfeeds. Meanwhile, Corey has been driving back and forth to take care of their three other kids.

NBC News spoke with six doctors across five states — California, Illinois, Massachusetts, North Carolina and Rhode Island — all of whom said pediatric hospital bed capacity has been strained due to an influx of RSV patients.

“We’re really having a capacity problem like I’ve never seen before,” said Dr. Charlotte Boney, pediatrician-in-chief at Baystate Children’s Hospital in Springfield, Massachusetts.

The CDC said it does not keep a national count of RSV cases, hospitalization or deaths, but it tracks changes in the virus’ spread.

“We have observed a rise in RSV in multiple U.S. regions, and some regions are nearing seasonal peak levels,” a CDC spokesperson said.

Last week, nearly 5,000 tests came back positive, according to CDC data. That’s not far from the number in the same week of October 2021 but far higher than in October 2020.

Boney said her hospital experienced a higher volume of patients in September than ever recorded, many of whom had RSV. Her pediatric ICU was closed to new patients on Wednesday because no beds were available.

During a normal winter, her emergency room might see around 100 children a day, Boney said. It’s now seeing about 130 to 150. Many RSV patients in Massachusetts are being transferred to nearby states, she added.

Dr. Michael Koster, director of pediatric infectious diseases at Hasbro Children’s Hospital in Providence, Rhode Island, said his hospital has been treating some RSV patients from over 100 miles away.

Kamath said that in the area around Raleigh, Durham and Chapel Hill, “there have been nights when there has been one bed available between three institutions, which is very scary.”

At Comer Children’s Hospital in Chicago, hospital and ICU beds have been full for over a month. Dr. John Cunningham, the hospital’s physician-in-chief, said the emergency room is seeing a 150% higher volume than its usual for October. He said the hospital is treating around 10 to 30 RSV patients at a given time, so they occupy a large share of its 30 ICU and 60 emergency beds.

Cunningham’s hospital is directing some patients to other facilities, but it can take 24 hours for a transfer, and a child’s condition could easily deteriorate in that time.

“Depending on the severity, it’s not an exaggeration to say minutes, hours matter,” said Dr. Benny Joyner, medical director of the pediatric ICU at UNC hospitals in Chapel Hill, North Carolina.

In San Diego, 50 patients have tested positive for RSV over the last few days at Rady Children’s Hospital, according to Dr. John Bradley, the hospital’s medical director of infectious diseases. He said the volume of RSV patients is “two to three times what we’ve ever experienced.”

“In mid-October, an epidemic of RSV is basically unheard of in San Diego,” Bradley added.

What a severe RSV case looks like

Doctors said RSV is spreading earlier this year and resulting in more severe illness in some kids because many children weren’t exposed to respiratory viruses earlier in the pandemic due to masking and social distancing.

“All those infection control measures protected us from all these viruses. Now everyone has relaxed those measures and these viruses are back with a vengeance,” Boney said.

Doctors said they’ve seen many young kids who contracted RSV from an older sibling, who in turn was infected at school or day care. That’s how the Light family thinks Aesop got sick: They have a daughter in first grade, a son in pre-kindergarten and a 2-year-old daughter at home. The entire family had cold-like symptoms last week.

“It’s very much a contact illness,” Cunningham said. “Hand hygiene is really the key thing. The major way that it disperses is actually by direct contact, rather than by somebody coughing on you.”

Doctors said parents shouldn’t worry about every cough or runny nose, but they should look out for signs that a child is lethargic or breathing hard or fast.

“If your child, especially under the age of 2, is flaring the nostrils, grunting, head bobbing or you’re seeing sucking in around the collarbones or ribs, that’s much more concerning,” Koster said.

Kamath said many children who show up to the hospital aren’t able to eat or drink because they’re breathing so rapidly. If your child can’t consume liquids, Joyner said, “that’s a harbinger that you need to bring them in and get them evaluated.”

Aesop Light showed many of those warning signs, Corey said. Doctors told the Lights that their son needed oxygen support and tubes inserted into his nostrils to suction the mucus from his airways.

On Thursday, Aesop was finally able to breathe on his own.

Children hospitalized with RSV typically recover within two to three days, though “a small minority do end up in the ICU, and then sometimes even on the ventilator,” Kamath said.

ICU patients tend to recover within a week, according to Joyner.

RSV vaccines and treatments are on the horizon

Aside from breathing tubes, ventilators and supportive care like steroids or fluids, doctors don’t have many ways to treat RSV.

“There is no Paxlovid-like drug for RSV. There is no Tamiflu drug like we have for influenza,” Boney said.

One drug, a monoclonal antibody called Synagis, is approved for babies at high risk of severe RSV, such as those born premature or with chronic heart or lung problems. But doctors said they give that treatment sparingly.

However, Bradley said his San Diego hospital is set to participate in a clinical trial of an RSV antiviral from Pfizer later this year.

“I’ve already told Pfizer, ‘Hurry up, get the study up and running,’” he said. “We’re being overwhelmed with RSV, so it’d be easy to study the drug right now.”

Pfizer is also testing an RSV vaccine candidate, which was found to be nearly 86% effective in preventing severe illness in a late-stage trial of older adults. Another RSV vaccine candidate, from pharmaceutical company GSK, was found to be around 83% effective against the disease among adults ages 60 and up, according to data released Thursday.

Bradley predicted it will like take another few years for an RSV vaccine to become available. In the meantime, he said, oxygen support is highly effective.

“It’s purely a lung infection. This virus doesn’t go anywhere else in the body the way influenza does,” he said, adding that “once they get oxygen and the lungs work, the kids actually feel OK.”

https://www.cnbc.com/2022/10/15/surge-in-cases-of-rsv-a-virus-that-can-severely-sicken-infants-is-filling-hospital-beds.html

Prevalence of Online Sexual Offenses Against Children in the US

 David Finkelhor, PhD1Heather Turner, PhD1Deirdre Colburn, MA1

doi:10.1001/jamanetworkopen.2022.34471

Key Points

Question  What are the lifetime prevalence and characteristics of online and technology-facilitated sexual abuse against children and youth?

Findings  In this national survey study of 2639 individuals, lifetime exposures were as follows: online child sexual abuse, 15.6%; image-based sexual abuse, 11.0%; self-produced child sexual abuse images, 7.2%; nonconsensual sexting, 7.2%; online grooming by adults, 5.4%; revenge pornography, 3.1%; sextortion, 3.5%; and online commercial sexual exploitation, 1.7%.

Meaning  Varied subtypes of online sexual abuse have different prevalence rates.

Abstract

Importance  Sexual abuse is increasingly facilitated by technology, but the prevalence and dynamics of such offenses have not been well delineated, making it difficult to design prevention strategies.

Objective  To examine the frequency and characteristics of online and technology-facilitated sexual abuse against children and youth.

Design, Setting, and Participants  In this nationally representative online survey study performed from November 19 to December 29, 2021, young adults aged 18 to 28 years were asked retrospectively about their childhood (<18 years) experiences of online and technology-facilitated abuse. The 2639 participants were sampled from an online panel.

Main Outcomes and Measures  Participants were asked questions about 11 different kinds of online and technology-facilitated sexual abuse with follow-up questions about their dynamics and offenders. Prevalence rates were calculated for several cross-cutting concepts (online child sexual abuse, image-based sexual abuse, self-produced child sexual abuse images, nonconsensual sexting, online grooming by adults, revenge pornography, sextortion, and online commercial sexual exploitation). Survey weights were applied to obtain population prevalence estimates.

Results  A total of 2639 individuals (48.5% male, 49.8% female, and 1.8% other gender; 23.7% Hispanic, 12.6% non-Hispanic Black, 53.9% non-Hispanic White, 4.8% other race, and 5.0% ≥2 races) were surveyed. Childhood (before 18 years of age) prevalence rates were as follows: online child sexual abuse, 15.6% (SE, 1.0%); image-based sexual abuse, 11.0% (SE, 0.9%); self-produced child sexual abuse images, 7.2% (SE, 0.7%); nonconsensual sexting, 7.2% (SE, 0.7%); online grooming by adults, 5.4% (SE, 0.5%); revenge pornography, 3.1% (SE, 0.5%); sextortion, 3.5% (SE, 0.6%); and online commercial sexual exploitation, 1.7% (SE, 0.3%). The prime age of vulnerability across all categories was 13 to 17 years. Perpetrators in most categories were predominantly dating partners, friends, and acquaintances, not online strangers.

Conclusions and Relevance  The results of this national survey study suggest that a considerable portion of youth have experienced online child sexual abuse. Professionals planning prevention and intervention strategies for online sexual abuse should understand that dynamics include diverse episodes that are often extensions of dating abuse, sexual bullying, and sexual harassment, not only events perpetrated by adult internet predators.

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2797339

'Gender-Affirming Chest' Surgeries Increase by Nearly 5x in Teens

 Numbers of gender-affirming chest surgeries among transgender adolescents jumped 389% from 2016 to 2019, researchers reported.

Drawing on data from the Nationwide Ambulatory Surgery Sample, an estimated 1,130 chest reconstructive surgeries were performed on transgender and gender-diverse (TGD) adolescents during these years, Rishub Karan Das, BA, of Vanderbilt University School of Medicine in Nashville, and colleagues found.

Nearly all were masculinizing, with only 1.4% feminizing, the group wrote in a research letter appearing in JAMA Pediatrics.

Only about 100 of these surgeries were performed in 2016, after which they steadily became more popular, surpassing 200 surgeries in 2017 and 300 by 2018. Das and colleagues put the 2019 total at 489 (P<0.001 vs 2016).

Ages of the adolescents ranged from 12 to 17, with a median of 16.

For context, the researchers noted that approximately 300,000 adolescents between the ages of 13 and 17 identify as transgender in the U.S. today.

"Reconstructive genital surgery is typically not performed in adolescents, but masculinizing chest reconstruction (e.g., mastectomy) and feminizing chest reconstruction (e.g., augmentation mammaplasty) may be performed in outpatient and ambulatory surgery settings," the researchers explained.

A slew of recent data has suggested that gender-affirming care -- even in early adolescence -- is linked to improved mental health for TGD individuals. But this care has been put in jeopardy with many states recently introducing bills to block this gender-affirming care for youth.

Only 19.9% of adolescents who underwent gender-affirming chest surgeries in this sample also used gender-affirming hormone therapy.

As for psychiatric comorbidities, 21.1% had anxiety and 16.2% had depression -- the two most commonly reported.

Most surgeries (61.1%) were covered by private insurance. A total of 16.5% of individuals used public health insurance to cover the cost of surgery and 15.8% were self-pay. These percentages didn't change much during the study period. "Most TGD adolescents had either public or private health insurance coverage for these procedures, contrasting with the predominance of self-payers reported in earlier studies on TGD adults," Das and colleagues pointed out.

The median inflation-adjusted total cost of gender-affirming chest surgeries largely held study during this time period, at about $30,000 (interquartile range $21,285-$45,147). That being said, over half of those opting for gender-affirming chest surgeries had a family income over $82,000 annually.

Not surprisingly, there were wide racial disparities among surgery patients: in 2019, 77.9% were white, 12.2% were Hispanic, 2.7% were Black, 2.5% were Asian or Pacific Islander, and 0.5% were Native American. Around 4% were categorized as "other race."

Most adolescents included in the analysis lived in a densely population area -- 68% living in a county with over 1 million residents. Trending down from there, 21.9% lived in a moderately densely populated area and only 9.8% lived in a county with less than a quarter million residents.


Disclosures

The study was supported by a grant from the National Center for Advancing Translational Sciences Clinical and Translational Science Awards Program.

Das and co-authors reported no disclosures.

U.S. sues Cigna for overcharging Medicare Advantage program

 The United States has sued insurer Cigna Corp for overcharging the Medicare Advantage program, federal prosecutors in Manhattan said on Monday.

Prosecutors said Cigna obtained tens of millions of dollars in Medicare funds by submitting false diagnoses for patients in cases where providers retained by the company had not conducted the necessary tests.

"Cigna knew that, under the Medicare Advantage reimbursement system, it would be paid more if its plan members appeared to be sicker," Damian Williams, the top federal prosecutor in Manhattan, said in a statement.

Medicare Advantage is a program in which private insurers provide coverage to patients who opt out of the traditional Medicare program, a U.S. government-run health plan for seniors.

https://finance.yahoo.com/news/1-u-sues-cigna-corp-161207183.html

Abiomed: FDA Grants 510(k) Clearance for Impella Low Profile Sheath

 The United States Food and Drug Administration (FDA) has granted 510(k) clearance to Abiomed (Nasdaq: ABMD) for its Impella Low Profile Sheath. Compared to the existing 14 French (Fr) sheath used for placement of Impella CP, the new sheath maintains the same inner diameter, but reduces the outer diameter by nearly 2 Fr. As a result of its smaller size and other technological advancements, the Low Profile Sheath will facilitate easier Impella insertion and removal, reduce procedural steps and help improve outcomes.

https://finance.yahoo.com/news/u-fda-grants-510-k-115800158.html

Humana has edge over CVS Health to acquire Cano Health

 Humana has better odds than CVS Health of acquiring Cano Health because the insurer already has a right-of-refusal agreement with the company and a huge position in the Medicare Advantage market, according to market researcher Insider Intelligence.

CVS Health and Humana are among the potential buyers for Cano Health, a tech-driven primary care disruptor, Bloomberg and The Wall Street Journal reported recently. Humana has the right-of-refusal arrangement in the event of a sale as part of a 2019 agreement with Cano, the Journal reported.

Whoever wins the bidding war will gain a strong foothold in senior primary care, as about 44 percent of Cano Health's patients are on Medicare Advantage, a value-based care program for seniors, Insider Intelligence reported. Humana is already second in the Medicare Advantage market behind UnitedHealthcare.

If CVS Health loses out on the acquisition, it could turn its attention to other primary care disruptors that serve seniors, including Oak Street Health and ChenMed, according to Insider Intelligence.

Either way, expect both CVS Health and Humana to look to get bigger. "There is no one-and-done asset," Shawn Guertin, CVS Health's executive vice president and CFO, said during the company's second-quarter earnings call, as Insider Intelligence reported.

https://www.beckershospitalreview.com/disruptors/humana-has-edge-over-cvs-health-to-acquire-cano-health-report.html